EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Roles of CDR2 and CDR2L in Anti-Yo Paraneoplastic Cerebellar Degeneration: A Literature Review

Pablo S Martínez Lozada iD, Rafael Mancero Montalvo, Andrea Iturralde Carrillo, Maria Montesdeoca-Lozada, Jose A Rodas iD, Jose E Leon-Rojas iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms26010070 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Pablo S Martínez Lozada und 5 weiteren Autor:innen. Beteiligte Einrichtung: NeurALL Research Group, Quito 170157, Ecuador. Hauptthemen laut MEDLINE: Paraneoplastic Cerebellar Degeneration, Autoantibodies, Nerve Tissue Proteins, Membrane Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad de las Américas.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Paraneoplastic cerebellar degeneration (PCD) is a rapidly progressive, immune-mediated syndrome characterized by the degeneration of Purkinje cells, often associated with the presence of antibodies targeting intracellular antigens within these cells. These autoantibodies are implicated in the induction of cytotoxicity, leading to Purkinje cell death, as demonstrated in in vitro models. However, the precise roles of antibodies and T lymphocytes in mediating neuronal injury remain a subject of ongoing research, with T cells appearing to be the main effectors of cerebellar injury. Notably, at least 50% of PCD cases involve anti-Yo autoantibodies, also referred to as anti-PCA1 (Purkinje cell antigen 1) antibodies, which specifically target cerebellar degeneration-related protein 2 (CDR2) and its paralogue, CDR2-like (CDR2L). Another recognized antigen is CDR 34, a 34 kDa Purkinje cell antigen characterized by tandem repeats and a B-cell epitope; its detection in non-cerebellar tissues necessitates further in situ hybridization studies. Onconeural antigens are expressed in both Purkinje cells and tumour cells, where they localize in the cytoplasm and associate with membrane-bound and free ribosomes, playing critical roles in regulating transcription and calcium homeostasis. Recent studies suggest that the breakdown of immune tolerance is linked to genetic alterations in tumour cell antigens, leading to the formation of neoantigens that can elicit autoreactive T cells, which may underscore the function of Yo antibodies. In vitro studies indicate that anti-Yo antibodies can induce cell death independent of T lymphocytes. The disease progresses by initial lymphocytic infiltration, followed by a rapid loss of Purkinje cells without significant inflammation. However, in vivo models showcase that anti-Yo PCD is primarily T-cell mediated, with antibodies serving as biomarkers rather than direct effectors of neuronal death. This review examines the mechanisms underlying PCD, focusing on the roles of CDR2 and CDR2L in tumour development and their potential role in the degeneration of cerebellar Purkinje neurons. A comprehensive understanding of these processes is essential for advancing diagnostic, prognostic, and therapeutic strategies for PCD and associated malignancies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Paraneoplastic Cerebellar DegenerationAutoantibodiesNerve Tissue ProteinsMembrane ProteinsHumansPurkinje CellsAnimalsAutoantigens

Stichwörter der Autor:innen

CDR2CDR2Lanti-Yoneuroimmunologyparaneoplastic cerebellar degeneration

Substanzen

CDR2 protein, humanAutoantibodiesNerve Tissue ProteinsCDR2L antigen, humanMembrane ProteinsAutoantigens

Autor:innen und Institutionen

  • NeurALL Research Group, Quito 170157, Ecuador.
  • Medical School, Universidad Internacional del Ecuador (UIDE), Quito 170411, Ecuador.
  • School of Psychology, University College Dublin, D04 V1W8 Dublin, Ireland.
  • Escuela de Psicología, Universidad Espíritu Santo, Samborondón 092301, Ecuador.
  • Cerebro, Emoción y Conducta, School of Medicine, Universidad de las Américas (UDLA), Quito 170124, Ecuador.

ORCID-Profile: Pablo S Martínez Lozada, Jose A Rodas, Jose E Leon-Rojas

Förderung

  • Universidad de las Américas

Zitieren

APA

Martínez Lozada, P. S., Mancero Montalvo, R., Iturralde Carrillo, A., Montesdeoca-Lozada, M., Rodas, J. A., & Leon-Rojas, J. E. (2024). Roles of CDR2 and CDR2L in Anti-Yo Paraneoplastic Cerebellar Degeneration: A Literature Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26010070

Vancouver

Martínez Lozada PS, Mancero Montalvo R, Iturralde Carrillo A, Montesdeoca-Lozada M, Rodas JA, Leon-Rojas JE. Roles of CDR2 and CDR2L in Anti-Yo Paraneoplastic Cerebellar Degeneration: A Literature Review. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms26010070

BibTeX
@article{MartnezLozada2024,
  author = {Martínez Lozada, Pablo S and Mancero Montalvo, Rafael and Iturralde Carrillo, Andrea and Montesdeoca-Lozada, Maria and Rodas, Jose A and Leon-Rojas, Jose E},
  title = {Roles of CDR2 and CDR2L in Anti-Yo Paraneoplastic Cerebellar Degeneration: A Literature Review},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms26010070}
}
Kostenlos starten →